Literature DB >> 9358776

Carcinoma of the common bile duct with superficial spread to the intrahepatic segmental bile ducts: a case report.

M Kato1, Y Nimura, J Kamiya, S Kondo, M Nagino, M Miyachi, M Kanai, H Igaki, S Maeda.   

Abstract

A 54-year-old woman presented with jaundice. Percutaneous transhepatic biliary drainage, cholangiography via a percutaneous transhepatic biliary, drainage catheter, and percutaneous transhepatic cholangioscopy were performed to alleviate the jaundice and to evaluate her biliary system. A diffuse-type tumor was detected in the common bile duct. The tumor had spread superficially up to the right anterior segmental duct and the left hepatic duct and involved the caudate branches. Curative surgery, which included a right anterior segmentectomy, total caudate lobectomy, and pylorus-preserving pancreatoduodenectomy, was performed. The histopathologic diagnosis was moderately differentiated tubular adenocarcinoma originating at the common bile duct. The extent of the superficial spread of the tumor corresponded to our preoperative determination. Her postoperative recovery was uneventful. In this case report, we discuss the accurate preoperative diagnosis and rational surgical treatment of bile duct carcinoma with superficial spread.

Entities:  

Mesh:

Year:  1997        PMID: 9358776

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  Staging cholangiocarcinoma by cholangioscopy.

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

2.  Radical surgery: vascular and pancreatic resection for cholangiocarcinoma.

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

3.  Superficially spreading cholangiocarcinoma.

Authors:  Motoki Abe; Satoshi Kondo; Satoshi Hirano; Yoshiyasu Ambo; Eiichi Tanaka; Katsunori Saito; Toshiaki Morikawa; Shunichi Okushiba; Hiroyuki Katoh
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 4.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.